logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Gliknik Inc.


USPTO Granted Patents = 17



Trademarks = 1

Forward Citations = 147

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal David S Block (17 out of 17 patents)

silverMedal Henrik Olsen (17 out of 17 patents)

bronzeMedal Scott E Strome (7 out of 21 patents)

4.  Dan H Schulze (7 out of 8 patents)

5.  Emmanuel Y Mérigeon (3 out of 3 patents)


17 patents:

1. 12337026 - Methods of treating inflammatory disorders with multivalent Fc compounds (2025-06-24),
2. 12195499 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2025-01-14),
3. 12122836 - Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement binding (2024-10-22),
4. 12084482 - Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions (2024-09-10),
5. 11795193 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2023-10-24),
6. 11331372 - Methods of treating inflammatory disorders with multivalent Fc compounds (2022-05-17),
7. 11155574 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2021-10-26),
8. 11117940 - Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions (2021-09-14),
9. 11034775 - Cysteine-optimized stradomers (2021-06-15),
10. 10941191 - Immunoglobulin constant region Fc receptor binding agents (2021-03-09),
11. 10851154 - Immunoglobulin constant region Fc receptor binding agents (2020-12-01),
12. 10208105 - Immunoglobulin constant region Fc receptor binding agents (2019-02-19),
13. 9926362 - Immunoglobulin constant region Fc receptor binding agents (2018-03-27),
14. 9683044 - Molecules with antigen binding and polyvalent FC gamma receptor binding activity (2017-06-20),
15. 9512210 - Immunoglobulin constant region Fc receptor binding agents (2016-12-06),
Company Overview
Gliknik Inc. is a biotechnology company based in Baltimore, Maryland, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing the power of the immune system to create treatments for various diseases, including cancer and autoimmune disorders. With a commitment to advancing medical science, Gliknik employs cutting-edge research methodologies and collaborates with academic and industry partners to bring novel therapies from concept to clinical application.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#30 in Baltimore, MD

#262 in Maryland

#18,881 in US

#35,887 in the World

Baltimore, MD (US)
Baltimore, MD, United States of America

Gliknik Inc.

Forward Citations = 147

5 inventors:

goldMedal David S Block (17 out of 17 patents)

silverMedal Henrik Olsen (17 out of 17 patents)

bronzeMedal Scott E Strome (7 out of 21 patents)

4.  Dan H Schulze (7 out of 8 patents)

5.  Emmanuel Y Mérigeon (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gliknik Inc.. Retrieved from https://idiyas.com/company/gliknik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…